PlainRecalls
FDA Drug Moderate Class II Terminated

Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.

Reported: February 15, 2023 Initiated: January 31, 2023 #D-0268-2023

Product Description

Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.

Reason for Recall

Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.

Details

Recalling Firm
BIOCON PHARMA INC
Units Affected
3665 bottles
Distribution
Nationwide in the USA
Location
ISELIN, NJ

Frequently Asked Questions

What product was recalled?
Posaconazole Delayed-Release Tablets, 100 mg, 60-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009; Manufactured by: Biocon Pharma Limited, Bengaluru, India - 560 099, NDC 70377-038-11.. Recalled by BIOCON PHARMA INC. Units affected: 3665 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 15, 2023. Severity: Moderate. Recall number: D-0268-2023.